Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Inhalación tardía de corticosteroides (≥ 7 días) para reducir la displasia broncopulmonar en lactantes prematuros

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD002311.pub3Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 18 April 2012see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Neonatal Group

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Wes Onland

    Correspondence to: Department of Neonatology, Emma Childrens' Hospital AMC, University of Amsterdam, Meibergdreef 9, Netherlands

    [email protected]

  • Martin Offringa

    Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, Canada

  • Anton van Kaam

    Department of Neonatology, Emma Children's Hospital AMC, University of Amsterdam, Meibergdreef 9, Netherlands

Contributions of authors

Drs Onland and D. van Kaam have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Onland, van Kaam.
Acquisition of data: Onland, van Kaam.
Analysis and interpretation of data: Onland, Offringa, van Kaam.
Drafting of the manuscript: Onland, van Kaam.
Critical revision of the manuscript for important intellectual content: Onland, Offringa, van Kaam.
Stastical analysis: Onland.
Study supervision: Offringa, van Kaam

Sources of support

Internal sources

  • Department of Neonatology, AMC, Amsterdam, Netherlands.

  • Department of Pediatric Clinical Epidemiology, AMC, Netherlands.

External sources

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA.

    Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C.

Declarations of interest

No financial disclosure to be declared. No potential conflicts of interest known.

Acknowledgements

Dr P Lister, Dr R Iles, Dr B Shaw, Dr F Ducharme for writing the previous version of this review, named "Inhaled steroids for neonatal chronic lung disease".
Dr David Schwartz, Dr T Giep, Prof M Silverman and Dr Spencer Brudno provided additional information for the previous version of this review.
Prof Silverman and Dr Jonsson provided precious additional data for this updated version of the review.
Ms Diane Haughton, Ms Yolanda Montagne and Prof Roger Soll of the Cochrane Neonatal Review Group.

Version history

Published

Title

Stage

Authors

Version

2022 Dec 15

Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Review

Wes Onland, Martin Offringa, Anton Kaam

https://doi.org/10.1002/14651858.CD002311.pub5

2017 Aug 24

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Review

Wes Onland, Martin Offringa, Anton van Kaam

https://doi.org/10.1002/14651858.CD002311.pub4

2012 Apr 18

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Review

Wes Onland, Martin Offringa, Anton van Kaam

https://doi.org/10.1002/14651858.CD002311.pub3

2010 Jan 20

Inhaled steroids for neonatal chronic lung disease

Review

Paula Lister, Richard Iles, Ben NJ Shaw, Francine M Ducharme

https://doi.org/10.1002/14651858.CD002311.pub2

1999 Oct 25

Inhaled steroids for neonatal chronic lung disease

Review

Paula Lister, Richard Iles, Ben NJ Shaw, Francine Ducharme

https://doi.org/10.1002/14651858.CD002311

Notes

Editorial responsibility for the review "Inhaled steroids for neonatal chronic lung disease" has been transferred to the Cochrane Neonatal Review Group from the Cochrane Airways Group.
A new team of review authors has been assigned ‐ Dr Wes Onland, Dr Anton Van Kaam, Dr Martin Offringa.

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.